Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.48
0.131.56%
Last update: Oct 19, 4:00 PM
$8.48
0.131.56%
Prothena Corp PLC (PRTA) Stock Price, Quote, News & History
PRTANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Prothena Corp (NASDAQ:PRTA) through any online brokerage.
Other companies in Prothena Corp’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Prothena Corp has a consensus price target of $27.82.
The stock price for Prothena Corp (NASDAQ: PRTA) is $8.48 last updated October 19, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Prothena Corp.
Prothena Corp does not have any upcoming earnings scheduled.
There is no upcoming split for Prothena Corp.
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
